
SL SCIENCE HOLDING LTD
SLBTNASDAQTrading Snapshot
- Day Range
- $2.64 β $2.71
- 52-Week Range
- $2.54 β $14.50
- Volume
- $3.20B
- Avg Volume
- $2.90B
- Shares Outstanding
- 560.8M
- Next Earnings
- Sep 20, 2026
Fundamentals Snapshot
- Annual Revenue
- $2M
- Last Q Revenue
- $525,874
- P/E Ratio
- 0.0
- P/S Ratio
- 681.4x
- EPS (TTM)
- $0.00
- Dividend Yield
- 0.00%
Why Investors Own SLBT
- βHigh-growth profile β revenue up +37.5% YoY with expanding US Equity exposure.
- βHealthy economics β 51% gross margin and 17% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About SL SCIENCE HOLDING LTD
Horizon Space Acquisition II Corp. aims to achieve strategic business combinations with other companies. This objective can be fulfilled through various transactional structures, including mergers, exchanges of shares, acquisitions of assets, direct purchases of stock, recapitalizations, or other forms of corporate reorganization. The firm was founded in 2023 and maintains its headquarters in New York, New York.
Otter Score Breakdown
βAnalyst Price Target
βLatest News & Updates
SL Science Announces Publication Of Peer-Reviewed Article In 'Biomedicines' Outlining A Rigorous Development Framework For Ξ³Ξ΄ T Cell Therapy In Glioblastoma
Glioblastoma a common and aggressive primary brain cancer in adults. Beyond reviewing existing literature, the paper outlines the specific clinical trial designs, biological measurements, and testing conditions required

12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Universe Pharmaceuticals (NASDAQ:UPC) shares increased by 108.5% to $6.59 during Monday's regular session. The market value of their outstanding shares is at $2.0 million. SL Science Holding (NASDAQ:SLBT)

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Nuwellis (NASDAQ:NUWE) stock rose 119.0% to $4.14 during Thursday's pre-market session. GlucoTrack (NASDAQ:GCTK) stock increased by 47.36% to $0.42. The market value of their outstanding shares is at $1.8

SL Science Announces Successful Exhibition of Breakthrough Brain Cancer Therapy Research at the 2026 World Congress of Basic and Clinical Pharmacology
Joint presentation with Taipei Medical University, JY BioMed, and HeXun Biosciences highlighted the power of gamma delta (Ξ³Ξ΄) T cells in eliminating glioblastoma in preclinical studies. TAIPEI, TAIWAN, July 17, 2026 (GLOBE NEWSWIRE) -- SL Science Holding Limited (NASDAQ: SLBT) ("SL Science" or the "Company"), a biotechnology company developing next-generation immune cell therapies, today announced its successful exhibition and participation at the 2026 World Congress of Basic and Clinical Pharma
SL Science Presents Benefits Of Gamma Delta T Cells In Eliminating Glioblastoma In Preclinical Studies At The 2026 World Congress Of Basic And Clinical Pharmacology
SL Science Holding Limited (NASDAQ:SLBT) ("SL Science" or the "Company"), a biotechnology company developing next-generation immune cell therapies, today announced its successful exhibition and

Ericsson, Q32 Bio And Other Big Stocks Moving Lower In Tuesdayβs Pre-Market Session
U.S. stock futures mixed, Nasdaq 100 up 100 pts. Telefonaktiebolaget LM Ericsson falls 9.2% in pre-market. Other stocks moving lower in pre-market.